Possible involvement of placental proteases in bradykinin (BK) degradation

Reproduction, Fertility and Development

Volumn 9, Issue 6, 1997, Pages 633-639

  Kuno, N ^a   Mizutani, S ^a   Ohno, Y ^a   Goto, K ^a   Itakura, A ^a   Kondo, I ^a   Kurauchi, O ^a   Kikkawa, F ^a   Tomoda, Y ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiotensin converting enzyme (ACE); Endopeptidase 24.11; Kininase I

Indexed keywords

BRADYKININ; DIPEPTIDYL CARBOXYPEPTIDASE; PROTEINASE;

ARTICLE; ENZYME ACTIVITY; ENZYME LOCALIZATION; FEMALE; FETOPLACENTAL UNIT; HUMAN; HUMAN TISSUE; PLACENTA; PREGNANCY;

3-MERCAPTOPROPIONIC ACID; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ARGININE; BLOOD; BRADYKININ; CAPTOPRIL; ENDOPEPTIDASES; FEMALE; GLYCOPEPTIDES; HUMANS; HYDROLYSIS; LYSINE CARBOXYPEPTIDASE; MICROSOMES; NEPRILYSIN; PEPTIDYL-DIPEPTIDASE A; PHENYLALANINE; PLACENTA; PREGNANCY;

EID: 0031462422     PISSN: 10313613     EISSN: None     Source Type: Journal    
DOI: 10.1071/R96045     Document Type: Article

References (36)

1. Binder, N. D., and Faber, J. J. (1992). Effects of captopril on blood pressure, placental blood flow and uterine oxygen consumption in pregnant rabbits. J. Pharmacol. Exp. Ther. 260, 294-9.
2. Bonner, G., Schunk, O., and Kaufman, W. (1985). Direct hypotensive action of intravascular bradykinin in man. Cardiology 72 Suppl. 1, 190-3.
3. Broughton Pipkin, F., and Symonds, E. M. (1977). Factors affecting angiotensin II concentrations in the human infant at birth. Clin. Sci. Mol. Med. 52, 449-56.
4. Chung, F. Y., and Donovan, M. D. (1995). Presystemic bradykinin metabolism in sheep and rat nasal homogenates. J. Pharmaceut. Sci. 84, 794-8.
5. Diz, D. I. (1985). Bradykinin and related peptides in central control of the cardiovascular system. Peptides 6 Suppl. 2, 57-64.
6. Ervin, M. G., Kullama, L. K., Ros, M. G., Leake, R. D., and Fisher, D. A. (1993). Vasopressin receptors and effects during fetal development. Reg. Peptide 45, 203-8.
7. Hanssens, M., Keirse, M. J. N. C., Vaneklecom, D. F., and Van Assche, F. A. (1991). Fetal and neonatal effects of treatment with angiotensin-converting enzyme inhibitors in pregnancy. Obstet. Gynecol. 78, 128-35.
8. Hooper, N. M., Hryszko, J., Oppong, S. Y., and Turner, A. J. (1992). Inhibition by converting enzyme inhibitors of pig kidney aminopeptidase P. Hypertension 19, 281-5.
9. Ishida, Y., Fujita, T., and Asai, N. (1981). New detection and separation method for amino acids by high-performance liquid chromatography. J. Chromatogr. 204, 143-8.
10. Ito, Y., Mizutani, S., Kurauchi, O., Kasugai, M., Narita, O., and Tomoda, Y. (1989). Purification and properties of microsomal carboxypeptidase N (kininase I) in human placenta. Enzyme 42, 8-14.
11. Madeddu, P., Parpaglia, P. P., Demontis, M. P., Varoni, M. V., Fattaccio, M. C., Anania, V., and Glorioso, N. (1995). Effects of kinin blockade on the blood pressure of salt-loaded pregnant rats. Hypertension 25(2), 823-7.
12. 9-BK in plasma. Can. J. Physiol. Pharmacol. 59, 131-8.
13. McDermott, J. R., Gibson, A. M., and Turner, J. D. (1987). Involvement of endopeptidase 24-15 in the inactivation of bradykinin by rat brain slices. Biochem. Biophys. Res. Comm. 146, 154-8.
14. Melmon, K. L., Cline, M. H., Hughest, T., and Nies, A. S. (1968). Kinins: possible mediators of neonatal circulatory changes in man. J. Clin. Invest. 47, 1295-302.
15. Minami, M., Togashi, H., Sano, M., Endo, T., Saito, H., Hashimoto, F., Fujita, K., Yasuda, H., Kurimoto, Y., and Nisho, T. (1983). Plasma bradykinin concentration in patients with essential hypertension, effort angina and other cardiac diseases. Folia Pharmacol. Japon. 82, 159-69.
16. Mizutani, S., Akiyama, H., Kurauchi, O., Taira, H., Narita, O., and Tomoda, Y. (1985). Plasma angiotensin I and serum placental leucine aminopeptidase (P-LAP) in pre-eclampsia. Arch. Gynecol. 236, 165-72.
17. Mizutani, S., Ito, Y., Nomura, S., Kurauchi, O., Kasugai, M., Narita, O., and Tomoda, Y. (1989). Increased sensitivity to bradykinin in pregnant rats. Res. Commun. Chem. Pathol. Pharmacol. 64, 373-80.
18. Mizutani, S, Goto, K., Itakura, A., Furuhashi, M., Kurauchi, O., Kikkawa, F., and Tomoda, Y. (1994a). Physiological role of placental proteases: interaction between pregnancy-induced bioactive peptides and proteases. Endcr. J. 41 Suppl, S93-S104.
19. Mizutani, S., Goto, K., Kurauchi, O., Kikkawa, F., and Tomoda, Y. (1994b). Aminopeptidase P in human placenta and pregnancy serum. Med. Sci. Res. 22, 127-30.
20. Mizutani, S., Goto K., Safwat, M., Itakura, A., Kurauchi O., Kikkawa, F., and Tomoda, Y. (1994c). Initiating enzymes of angiotensin II degradation in human placenta and pregnancy serum. Med. Sci. Res. 22, 537-44.
21. Mizutani, S., Goto, K., Mizuno, K., Itakura, A., Kurauchi, O., Kikkawa, F., and Tomoda, Y. (1995). Interaction between pregnancy-induced bioactive peptides and the placental proteases. Reprod. Fertil. Dev. 7, 1431-6.
22. Nagaoka, I., and Yamashita, T. (1986). Possible involvement of angiotensin I-converting enzyme in the inactivation of bradykinin by intact macrophages. Biochem. Biophys. Acta 886, 231-42.
23. Oosterbaan, H. P., and Swaab, D. F. (1989). Amniotic oxytocin and vasopressin in relation to human fetal development and labour. Early Hum. Dev. 19, 253-62.
24. Oya, M., Wakabayashi, T., Yoshino, M., and Mizutani, S. (1974). The origin of human pregnancy serum oxytocinase. Gynecol. Invest. 5, 276-83.
25. Ryan, J. W., Berryer, P., Chung, A. Y. K., and Sheffy, D. H. (1994). Characterization of rat pulmonary vascular aminopeptidase P in vivo: role in the inactivation of bradykinin. J. Pharmac. Exp. Ther. 269, 941-7.
26. Salgado, M. C., Rabito, S. F., and Carretero, O. A. (1986). Blood kinin in one-kidney, one-clip hypertensive rats. Hypertension 8 Suppl. 1, 110-3.
27. Sheikh, I. A., and Kaplan, A. P. (1989). Mechanism of digestion of bradykinin and lysylbradykinin (kallidin) in human serum. Biochem. Pharmacol. 38, 993-1000.
28. Skidgel, R. A. (1992). Bradykinin-degradation enzymes: structure, function, distribution, and potential roles in cardiovascular pharmacology. J. Cardiovasc. Pharmacol. 20 Suppl 9, S4-S9.
29. Soares de Moura, R., and Solano Vale, N. (1986). Effect of captopril on bradykinin inactivation by human fetal placental circulation. Br. J. Clin. Pharmac. 21, 143-8.
30. Taira, H., Mizutani, S., Narita, O., and Tomoda, Y. (1985) Angiotensin I-converting enzyme in human placenta. Placenta 6, 543-9.
31. Ura, N., Carretero, O. A., and Erdös, E. G. (1987). Role of renal endopeptidase 24.11 in kinin metabolism in vitro and in vivo. Kid. Intern. 32, 507-13.
32. van Leeuwen, B. H., Millar, J. A., Hammat, M. T., and Johnston, C. E. (1983). Radioimmunoassay of blood bradykinin: purification of blood extracts to prevent cross-reaction with endogenous kininogen. Clin. Chim. Acta 127, 343-51.
33. Waeber, B., Aubert, J. F., Nussbrger, J., Vavver, R., Stewart, J. M., and Brunner, H. R. (1987). Influence of bradykinin on blood pressure regulation of spontaneously hypertensive rats maintained on different sodium intake. Clin. Exp. Pharmac. Physiol. 14, 659-64.
34. Weir, R. J., Brown, J. J., Franser, R., Kraszewski, A., Lover, A. F., McIlwaine, G. M., Norton, J. J., Robertson, J. I. S., and Tree, M. (1973). Plasma renin, renin substrate, angiotensin II, and adolosterone in hypertensive disease of pregnancy. Lancet 1, 291-4.
35. Wilk, S., and Orlowski, M. (1979). Degradation of bradykinin by isolated neutral endopeptidase of brain and pituritary. Biochem. Biophys. Res. Commun. 90, 1-6.
36. Wilkes, B. M., and Mento, P. F. (1988). Bradykinin-induced vasoconstriction and thromboxane release in perfused human placenta. Am. J. Physiol. 254, E681-6.